SLIT2 and neoplasm: Importantly, this aberrant tumor angiogenesis prevents the delivery of therapeutic agents and its mechanisms remain incompletely understood, although proangiogenic signaling molecules, including VEGF-A, angiopoietins and SLIT2 are known to be involved [19–22].